Governor Baker addresses Massachusetts’ life sciences commitment at BIO International Convention

| Posted by | Categories: Grow, Innovate, Learn, Work

Governor Charlie Baker addressed the 2017 BIO International Convention in San Diego this week to reinforce Massachusetts’ commitment to the life sciences sector as tech and innovation firms around the globe look to expand. Governor Baker also welcomed attendees to the 2018 BIO International Convention, which will be hosted at the Boston Convention & Exhibition Center (BCEC) in June 2018.

Here is a video of Governor Baker’s speech.

Earlier in the week, the Baker-Polito Administration announced a legislative proposal to bolster Massachusetts’ leadership in the life sciences sector, which would provide up to $500 million over five years for strategic investments in public infrastructure, research and development, workforce training and education, including up to $295 million in capital authorization and up to $150 million job-creating tax incentives.

Governor Baker said, “We are committed to supporting the public-private partnerships and strategic investments that have made Massachusetts a global leader in the life sciences, research, development and medical advancements. This proposal empowers the Commonwealth and the Massachusetts Life Sciences Center to continue that success, attracting world-class companies in innovation and technology, giving researchers the best available tools and educational environment, training our workforce and providing successful careers here in Massachusetts.”

Lieutenant Governor Karyn Polito said, “Our administration has a strong commitment to increasing educational opportunities in science, technology, engineering and math for students across Massachusetts. We have a talented pipeline ready to lead and learn in the life sciences, and through this proposal, we are excited to provide more opportunities for the Commonwealth’s fastest growing industry.”

The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO) which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.